Market Research Logo

Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017

1. Age-Related Macular Degeneration: Disease Overview
1.1. Age-Related Macular Degeneration Symptoms
1.2. Age-Related Macular Degeneration Etiology
1.3. Age-Related Macular Degeneration Diagnosis
1.4. Age-Related Macular Degeneration Treatment Options
2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials
3. Age-Related Macular Degeneration Epidemiology Analysis
4. US Age-Related Macular Degeneration Market Insights
4.1. Marketed Products for Age-Related Macular Degeneration in US
4.2. US Age-Related Macular Degeneration Market Size & Forecast
4.3. US Age-Related Macular Degeneration Product Sales Forecast
4.4. US Age-Related Macular Degeneration Market Share Analysis
5. Germany Age-Related Macular Degeneration Market Insights
5.1. Marketed Products for Age-Related Macular Degeneration in Germany
5.2. Germany Age-Related Macular Degeneration Market Size & Forecast
5.3. Germany Age-Related Macular Degeneration Product Sales Forecast
5.4. Germany Age-Related Macular Degeneration Market Share Analysis
6. France Age-Related Macular Degeneration Market Insights
6.1. Marketed Products for Age-Related Macular Degeneration in France
6.2. France Age-Related Macular Degeneration Market Size & Forecast
6.3. France Age-Related Macular Degeneration Product Sales Forecast
6.4. France Age-Related Macular Degeneration Market Share Analysis
7. Italy Age-Related Macular Degeneration Market Insights
7.1. Marketed Products for Age-Related Macular Degeneration in Italy
7.2. Italy Age-Related Macular Degeneration Market Size & Forecast
7.3. Italy Age-Related Macular Degeneration Product Sales Forecast
7.4. Italy Age-Related Macular Degeneration Market Share Analysis
8. Spain Age-Related Macular Degeneration Market Insights
8.1. Marketed Products for Age-Related Macular Degeneration in Spain
8.2. Spain Age-Related Macular Degeneration Market Size & Forecast
8.3. Spain Age-Related Macular Degeneration Product Sales Forecast
8.4. Spain Age-Related Macular Degeneration Market Share Analysis
9. UK Age-Related Macular Degeneration Market Insights
9.1. Marketed Products for Age-Related Macular Degeneration in UK
9.2. UK Age-Related Macular Degeneration Market Size & Forecast
9.3. UK Age-Related Macular Degeneration Product Sales Forecast
9.4. UK Age-Related Macular Degeneration Market Share Analysis
10. Europe Age-Related Macular Degeneration Market Insights
10.1. Europe Age-Related Macular Degeneration Market Size & Forecast
10.2. Europe Age-Related Macular Degeneration Product Sales Forecast
10.3. Europe Age-Related Macular Degeneration Market Share Analysis
11. Japan Age-Related Macular Degeneration Market Insights
11.1. Marketed Products for Age-Related Macular Degeneration in Japan
11.2. Japan Age-Related Macular Degeneration Market Size & Forecast
11.3. Japan Age-Related Macular Degeneration Product Sales Forecast
11.4. Japan Age-Related Macular Degeneration Market Share Analysis
12. Global Age-Related Macular Degeneration Market Insights
12.1. Global Age-Related Macular Degeneration Market Size & Forecast
12.2. Global Age-Related Macular Degeneration Product Sales Forecast
12.3. Global Age-Related Macular Degeneration Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2017
Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2017
Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2017
Table 4: Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Age-Related Macular Degeneration in US, 2017
Table 6: US Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 8: US Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 9: Marketed Products for Age-Related Macular Degeneration in Germany, 2017
Table 10: Germany Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 12: Germany Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 13: Marketed Products for Age-Related Macular Degeneration in France, 2017
Table 14: France Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 16: France Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 17: Marketed Products for Age-Related Macular Degeneration in Italy, 2017
Table 18: Italy Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 20: Italy Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 21: Marketed Products for Age-Related Macular Degeneration in Spain, 2017
Table 22: Spain Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 24: Spain Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 25: Marketed Products for Age-Related Macular Degeneration in UK, 2017
Table 26: UK Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 28: UK Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 29: Europe Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Age-Related Macular Degeneration in Japan, 2017
Table 32: Japan Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Table 34: Japan Age-Related Macular Degeneration Market Trends, 2012 - 2021
Table 35: Global Age-Related Macular Degeneration Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2017
Figure 2: Age-Related Macular Degeneration Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 4: US Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 5: US Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 6: US Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 7: Germany Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 8: Germany Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 9: Germany Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 10: Germany Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 11: France Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 12: France Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 13: France Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 14: France Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 15: Italy Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 16: Italy Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 17: Italy Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 18: Italy Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 19: Spain Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 20: Spain Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 21: Spain Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 22: Spain Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 23: UK Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 24: UK Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 25: UK Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 26: UK Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 27: Europe Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 28: Europe Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 29: Europe Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 30: Europe Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 31: Japan Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 32: Japan Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 33: Japan Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 34: Japan Age-Related Macular Degeneration Market - Future Market Share (%), 2021
Figure 35: Global Age-Related Macular Degeneration Market Size ($mn), 2012 - 2021
Figure 36: Global Age-Related Macular Degeneration Product Sales ($mn), 2012 - 2021
Figure 37: Global Age-Related Macular Degeneration Market Share by Products (%), 2016
Figure 38: Global Age-Related Macular Degeneration Market - Future Market Share (%), 2021

Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Age-Related Macular Degeneration Market and Competitive Landscape – 2017, provides comprehensive insights into Age-Related Macular Degeneration pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Age-Related Macular Degeneration market size and drug sales. This research also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.
The report is classified into twelve sections – Age-Related Macular Degeneration overview with definitions, symptoms, etiology, diagnosis, treatment options; Age-Related Macular Degeneration pipeline insights covering late stage clinical trials pipeline; Age-Related Macular Degeneration prevalence trends by countries; Age-Related Macular Degeneration market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Age-Related Macular Degeneration pipeline: Find out the drugs in clinical trials for Age-Related Macular Degeneration by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Age-Related Macular Degeneration epidemiology: Find out the prevalence of Age-Related Macular Degeneration by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Age-Related Macular Degeneration products: Identify key products marketed and prescribed for Age-Related Macular Degeneration by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Age-Related Macular Degeneration market size: Find out the market size for Age-Related Macular Degeneration drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Age-Related Macular Degeneration drug sales: Find out the sales of Age-Related Macular Degeneration drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Age-Related Macular Degeneration drugs sales forecast: Sales forecast for Age-Related Macular Degeneration drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Age-Related Macular Degeneration market share analysis: Find out the market shares of Age-Related Macular Degeneration drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report

;